GeneFerm Biotechnology Co., Ltd. - Laporan Laba Rugi (TTM)

GeneFerm Biotechnology Co., Ltd.
TW ˙ TPEX
NT$ 49.55 ↓ -0.15 (-0.30%)
2024-10-25
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi GeneFerm Biotechnology Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 360 368 393 431 472 522 552 585 617 634 674 752 781 794 728 612 549 521 569 621
Change (%) 2.36 6.82 9.66 9.51 10.55 5.75 5.93 5.51 2.69 6.29 11.60 3.86 1.63 -8.24 -15.92 -10.33 -5.09 9.22 9.13
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 258 246 250 272 294 330 352 367 394 412 433 482 497 507 489 443 428 424 452 479
Change (%) -4.64 1.67 8.63 7.99 12.22 6.91 4.04 7.50 4.46 5.05 11.37 3.11 2.15 -3.57 -9.55 -3.23 -0.90 6.47 6.03
% of Revenue 71.79 66.88 63.65 63.05 62.18 63.12 63.81 62.67 63.85 64.96 64.20 64.07 63.60 63.93 67.17 72.26 77.99 81.44 79.39 77.14
Gross Operating Profit 101 122 143 159 179 193 200 218 223 222 241 270 284 286 239 170 121 97 117 142
Change (%) 20.19 17.24 11.47 12.09 7.82 3.77 9.26 2.17 -0.45 8.57 12.02 5.20 0.74 -16.50 -28.96 -28.85 -19.95 21.28 21.04
% of Revenue 28.21 33.12 36.35 36.95 37.82 36.88 36.19 37.33 36.15 35.04 35.80 35.93 36.40 36.07 32.83 27.74 22.01 18.56 20.61 22.86
SG&A 82 82 83 85 87 90 91 94 96 96 97 101 102 104 106 101 102 102 104 106
Change (%) 0.36 0.10 2.84 2.93 3.31 1.24 3.24 1.82 -0.07 1.35 4.25 0.46 2.53 1.18 -4.55 1.39 -0.43 2.41 1.80
% of Revenue 22.83 22.39 20.98 19.67 18.49 17.28 16.54 16.12 15.56 15.14 14.44 13.49 13.04 13.16 14.51 16.47 18.63 19.54 18.32 17.09
R&D 22 22 22 23 23 24 24 24 24 24 25 27 28 28 28 28 28 29 31 32
Change (%) 0.92 0.12 0.81 1.72 2.43 0.66 0.63 -1.43 2.80 3.68 6.62 5.73 0.25 0.17 -2.03 1.68 3.67 4.38 3.78
% of Revenue 6.17 6.08 5.70 5.24 4.87 4.51 4.29 4.08 3.81 3.81 3.72 3.55 3.62 3.57 3.90 4.54 5.15 5.62 5.38 5.11
OpEx 363 351 355 380 404 443 468 485 514 532 555 610 627 640 623 571 559 556 587 617
Change (%) -3.17 1.20 6.79 6.49 9.73 5.42 3.71 5.95 3.54 4.32 9.90 2.78 2.12 -2.63 -8.36 -2.17 -0.58 5.62 5.16
% of Revenue 100.80 95.35 90.33 87.97 85.54 84.91 84.64 82.87 83.22 83.91 82.36 81.11 80.27 80.65 85.58 93.27 101.77 106.60 103.09 99.34
Operating Income -3 17 38 52 68 79 85 100 104 102 119 142 154 154 105 41 -10 -34 -18 4
Change (%) -695.89 122.18 36.47 31.60 15.41 7.61 18.16 3.35 -1.54 16.54 19.52 8.48 -0.35 -31.60 -60.79 -123.53 254.98 -48.95 -123.31
% of Revenue -0.80 4.65 9.67 12.03 14.46 15.09 15.36 17.13 16.78 16.09 17.64 18.89 19.73 19.35 14.42 6.73 -1.77 -6.60 -3.09 0.66
Interest Expense -10 -10 -9 -9 -8 -7 -6 -5 -4 -4 -4 -4 -4 -4 -4 -4 -4 -4 -5 -6
Change (%) -4.31 -5.18 -5.60 -8.78 -8.81 -12.70 -17.99 -14.99 -14.15 -5.08 5.65 7.07 1.68 -3.76 1.49 2.43 6.44 13.97 9.56
% of Revenue -2.85 -2.67 -2.37 -2.04 -1.70 -1.40 -1.16 -0.89 -0.72 -0.60 -0.54 -0.51 -0.53 -0.53 -0.55 -0.67 -0.76 -0.85 -0.89 -0.89
Net Income -13 5 22 32 46 57 67 86 93 93 103 120 129 125 86 33 -12 -23 -8 -1
Change (%) -134.30 376.02 48.24 44.05 24.71 15.97 29.46 8.42 0.00 10.67 16.23 6.98 -3.09 -31.12 -61.55 -136.66 86.21 -65.61 -89.43
% of Revenue -3.67 1.23 5.48 7.41 9.74 10.99 12.05 14.73 15.14 14.74 15.35 15.99 16.47 15.70 11.79 5.39 -2.20 -4.32 -1.36 -0.13

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista